Egliton 3 Injection 1's is an anti-cancer medicine used in the treatment of hairy cell leukaemia, follicular leukaemia, malignant leukaemia, AIDS-Related Kaposi’s Sarcoma, Hodgkin’s Lymphoma in combination with anthracycline-containing chemotherapy medicine, chronic hepatitis B and C. Cancer is a disease where the cells grow abnormally and divide uncontrollably. It can also be used when the cancer has spread to other parts of the body.
Egliton 3 Injection 1's contains Interferon alpha 2b as an active ingredient, which belongs to the class of immunomodulators. It works by inhibiting the abnormal growth of cancer cells. It also helps reduce the amount of hepatitis C virus (HCV) in the body.
Egliton 3 Injection 1's may cause certain side effects such as flu-like symptoms, diarrhoea, fatigue, nausea, headache, dizziness, vomiting, tiredness, and injection site reactions. If the side effects persist or bother you, consult your doctor. Egliton 3 Injection 1's will be administered by a trained doctor. Hence, do not self-administer.
Avoid taking it and inform your doctor if you are allergic to Egliton 3 Injection 1's or its components. Inform your doctor if you have any cardiovascular conditions, liver/kidney disease, autoimmune hepatitis, a history of autoimmune disease, or HIV infection, as it can cause adverse effects. $ is not recommended for use in pregnancy as it is known to cause fetal harm. Breastfeeding should be avoided when on treatment with Egliton 3 Injection 1's.